Sight Sciences reports MACs delay effective date of LCDs impacting OMNI and SION to January 29, 2024

Sight Sciences, Inc.

Five MACs delayed effective date of local coverage determinations on Micro-Invasive Glaucoma Surgery from Dec 24, 2023 to Jan 29, 2024.
LCDs identify certain procedures as investigational, including canaloplasty with trabeculotomy ab interno associated with OMNI Surgical System.
The states served by these five MACs accounted for approximately 63% of Sight Sciences' Surgical Glaucoma revenue in 2022.
Sight Sciences strongly disagrees with LCDs' characterization and is pursuing remediation, including engagement with MACs and CMS, and potential reconsideration request.
The company is still assessing potential impact on coverage for its SION Surgical Instrument technology.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.